Simplex Trading
AVXL icon

Simplex Trading’s Anavex Life Sciences AVXL Stock Holding History

Simplex Trading’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253K Sell
82,400
-7,500
-8% -$32.5K ﹤0.01% 4013
2025
Q4 		$320K Sell
89,900
-94,100
-51% -$576K ﹤0.01% 3746
2025
Q3 		$1.64M Buy
184,000
+103,900
+130% +$1.05M ﹤0.01% 2523
2025
Q2 		$738K Sell
80,100
-27,400
-25% -$234K ﹤0.01% 3106
2025
Q1 		$922K Buy
107,500
+33,200
+45% +$314K ﹤0.01% 2776
2024
Q4 		$797K Buy
74,300
+35,300
+91% +$272K ﹤0.01% 3071
2024
Q3 		$221K Buy
39,000
+21,900
+128% +$126K ﹤0.01% 4424
2024
Q2 		$72K Sell
17,100
-8,800
-34% -$35.6K ﹤0.01% 5708
2024
Q1 		$131K Sell
25,900
-15,800
-38% -$88.9K ﹤0.01% 5300
2023
Q4 		$388K Sell
41,700
-3,700
-8% -$25.5K ﹤0.01% 3959
2023
Q3 		$297K Buy
45,400
+1,300
+3% +$10.3K ﹤0.01% 3946
2023
Q2 		$358K Buy
44,100
+8,600
+24% +$73.7K ﹤0.01% 3650
2023
Q1 		$304K Sell
35,500
-92,800
-72% -$926K ﹤0.01% 3828
2022
Q4 		$1.19M Sell
128,300
-23,200
-15% -$248K ﹤0.01% 2306
2022
Q3 		$1.56M Buy
151,500
+16,200
+12% +$171K ﹤0.01% 2194
2022
Q2 		$1.35M Buy
135,300
+64,800
+92% +$614K ﹤0.01% 2282
2022
Q1 		$867K Buy
70,500
+2,900
+4% +$35.7K ﹤0.01% 3082
2021
Q4 		$1.17M Sell
67,600
-39,800
-37% -$756K ﹤0.01% 2661
2021
Q3 		$2.64M Buy
107,400
+4,000
+4% +$79.6K ﹤0.01% 1814
2021
Q2 		$2.36M Buy
+103,400
New +$1.53M ﹤0.01% 1954
2021
Q1 		– Sell
-590
Closed -$318K – 8770
2020
Q4 		$318K Sell
590
-14
-2% -$74 ﹤0.01% 3990
2020
Q3 		$274K Buy
604
+328
+119% +$1.41K ﹤0.01% 3707
2020
Q2 		$135K Buy
276
+244
+763% +$922 ﹤0.01% 4453
2020
Q1 		$10K Sell
32
-1,263
-98% -$4.4K ﹤0.01% 6453
2019
Q4 		$335K Sell
1,295
-149
-10% -$391 ﹤0.01% 3161
2019
Q3 		$456K Buy
1,444
+1,157
+403% +$3.34K ﹤0.01% 2714
2019
Q2 		$96K Buy
287
+44
+18% +$137 ﹤0.01% 4227
2019
Q1 		$74K Buy
243
+163
+204% +$389 ﹤0.01% 4646
2018
Q4 		$12K Sell
80
-22
-22% -$50 ﹤0.01% 5711
2018
Q3 		$27K Sell
102
-41
-29% -$116 ﹤0.01% 5721
2018
Q2 		$37K Buy
143
+54
+61% +$151 ﹤0.01% 5357
2018
Q1 		$5K Sell
89
-169
-66% -$478 ﹤0.01% 4589
2017
Q4 		$34K Sell
258
-1
-0.4% -$4 ﹤0.01% 2794
2017
Q3 		$33K Buy
259
+56
+28% +$249 ﹤0.01% 2676
2017
Q2 		$12K Sell
203
-50
-20% -$289 ﹤0.01% 3797
2017
Q1 		$11K Sell
253
-255
-50% -$1.32K ﹤0.01% 3861
2016
Q4 		$110K Buy
508
+61
+14% +$217 0.01% 1454
2016
Q3 		$150K Sell
447
-12
-3% -$51 0.01% 1239
2016
Q2 		$11K Buy
459
+186
+68% +$899 ﹤0.01% 3489
2016
Q1 		$28K Buy
273
+83
+44% +$365 ﹤0.01% 2475
2015
Q4 		$33K Buy
+190
New +$1.35K ﹤0.01% 2264

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Simplex Trading's AVXL Position: Q1 2026 in Review

Simplex Trading opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 47,867 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4654 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AVXL as recently as Q1 2025.

Simplex Trading first reported a position in AVXL in Q1 2016 and has held it in 29 quarters since. The position peaked at $671K in Q4 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Simplex Trading held 47,867 shares of Anavex Life Sciences worth $147K as of Q1 2026.
  • Anavex Life Sciences was a new Simplex Trading position in Q1 2026.
  • Anavex Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4654 holding.
  • Simplex Trading first reported a position in Anavex Life Sciences in Q1 2016 and has held it in 29 quarters since.
  • Simplex Trading's Anavex Life Sciences position peaked at $671K in Q4 2023.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.